Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Latest Breaking News

Showing Original Post only (View all)

BumRushDaShow

(173,659 posts)
Thu Jun 25, 2026, 06:48 AM Thursday

Sen. Maggie Hassan questions Trump administration over mystery weight loss drug patient [View all]

Source: MS NOW News

Jun. 24, 2026, 7:30 PM EDT


Sen. Maggie Hassan, D-N.H., on Wednesday questioned the Trump administration over the mystery individual who got exclusive access to a new weight loss drug that is not available to the general public. Hassan penned a letter to Health and Human Services Secretary Robert F. Kennedy Jr. expressing concern over reports that a “well-connected individual,” whom she suggested is President Donald Trump, received special, free access to the experimental weight loss drug retatrutide.

The New Hampshire Democrat shared the letter with MS NOW in an exclusive interview with “The Weeknight.” “We’ve got somebody highly connected in this administration who’s making special deals for one person and it just speaks to the whole way this administration operates,” Hassan told MS NOW. “They’re thinking about the highly connected, the wealthy.”

In her letter to Kennedy, the congresswoman said she was concerned that the administration was “bending the rules” by giving an individual special access to the drug through the Food and Drug Administration. “I am deeply concerned by new reporting that suggests you may be bending the rules of a federal program, and exerting improper political pressure, in order to provide a well-connected individual with free access to an exclusive prescription drug,” the senator wrote to Kennedy.

Hassan’s letter comes a day after Stat News reported that drug manufacturer Eli Lilly and the Food and Drug Administration allowed special access to retatrutide for a lone 79-year-old man in April through its “compassionate use” program.

Read more: https://www.ms.now/news/maggie-hassan-retatrutide-patient-white-house



Link to Sen. Hassan PRESS RELEASE - Senator Hassan Presses for Answers After Reports That Trump May Have Received Special, Free Access to Medication as Prescription Costs Soar

Link to LETTER (inquiry) (PDF) - https://www.hassan.senate.gov/imo/media/doc/624.26lettertorfkjr.pdf
10 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Latest Discussions»Latest Breaking News»Sen. Maggie Hassan questi...